查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493211

美國心室引流市場規模、佔有率、趨勢分析報告：按應用、按患者類型、按最終用途、按國家、細分市場預測，2024-2030 年

U.S. External Ventricular Drain Market Size, Share & Trends Analysis Report By Application, By Patient Type, By End-use, By Country, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

美國心室引流（EVD）市場成長與趨勢

根據Grand View Research, Inc.最新報告，預計到2030年，美國心室引流市場規模將達12億美元，預測期內複合年成長率為8.10%。

該市場受到多種因素的推動，例如新產品的推出、醫療保健支出的增加以及用於治療創傷性腦損傷的 EVD 設備的監管核准的增加。

在這個市場中，包括製造商、醫療保健提供者和監管機構在內的各種相關人員正在合作，以確保從各種類型出血中恢復的患者可以隨時獲得有效和安全的 EVD 解決方案。例如，2023 年 7 月，Integra LifeSciences 宣布對其 Codman Bactiseal EVD 導管套件在治療水腦症共用取得的成功進行了積極評價，顱內動脈瘤破裂導致蜘蛛膜下腔出(aSAH) 患者常見的併發症。結果凸顯了與使用這種醫療解決方案相關的積極的臨床和經濟成果。這項集體努力旨在提高受這種嚴重疾病影響的患者的整體護理品質和結果。

配戴 EVD 可以讓醫療服務提供者持續監測顱骨內的壓力，並做出必要的調整以排放液體。這種持續監測對於評估患者的神經狀態並提供及時介入至關重要。

美國心室引流市場報告亮點

  • 從產品來看，創傷性腦損傷領域預計在預測期內複合年成長率最快，達到 9.50%。 TBI 可導致腦室內出血（出血），需要使用 EVD 設備清除大腦中多餘的腦脊髓液。這將直接增加EVD設備的需求並推動市場成長。
  • 按患者類型分類，兒科領域預計在預測期內將以 9.56% 的複合年成長率成長最快，因為包括電腦斷層掃描和MRI 在內的兒科神經影像技術的進步正在提高兒童TBI 診斷的準確性和及時性。
  • 醫院在腦外傷、顱內壓（ICP）和水腦症等神經系統疾病的診斷和治療中發揮重要作用。作為患者照護的重要中心，這些設施通常擁有最先進的醫療技術並僱用熟練的醫療專業人員團隊。

目錄

第1章調查方法和範圍

第2章執行概述

第3章美國心室引流市場變數、趨勢、範圍

  • 市場體系展望
    • 助劑市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
  • 美國心室引流市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國心室引流市場：應用、估計與趨勢分析

  • 細分儀表板
  • 美國心室引流市場波動分析
  • 2018-2030 年美國心室引流市場規模與趨勢分析（按應用）
  • 創傷性腦損傷
  • 蜘蛛網膜下腔出血
  • 腦出血
  • 其他非外傷性水腦症

第5章美國心室引流市場：病患類型、估計與趨勢分析

  • 細分儀表板
  • 美國心室引流市場波動分析
  • 2018-2030 年美國心室引流市場規模與趨勢分析（依病患類型）
  • 成人
  • 孩子

第6章美國心室引流市場：最終用途、估計與趨勢分析

  • 細分儀表板
  • 美國心室引流市場波動分析
  • 2018-2030 年美國心室引流市場規模與趨勢分析（依最終用途）
  • 醫院
  • 其他

第7章美國心室引流市場：國家估計和趨勢分析（按應用、患者類型和最終用途）

  • 區域儀表板
  • 2018-2030年市場規模及趨勢分析
  • 南部
  • 西
  • 中西部
  • 東北

第8章 競爭格局

  • 市場參與企業分類
  • 主要企業簡介
    • Medtronic
    • Integra LifeSciences
    • SOPHYSA
    • Neuromedex
  • 熱圖分析/企業市場分析
  • 2023年企業市場佔有率評估分析
  • 其他主要市場參與企業名單
Product Code: GVR-4-68040-264-4

U.S. External Ventricular Drain Market Growth & Trends:

The U.S. external ventricular drain market size is anticipated to reach USD 1.2 billion by 2030, exhibiting a CAGR of 8.10% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by various factors such as novel product launches, rising healthcare expenditure, and increasing regulatory approval for EVD devices in traumatic brain injury treatment.

In this market, various stakeholders, including manufacturers, healthcare providers, and regulatory bodies, collaborate to ensure that effective and safe EVD solutions are readily available for patients recovering from different types of hemorrhage. For instance, in July 2023, Integra LifeSciences shared positive updates about the successful application of the Codman Bactiseal EVD catheter set in managing hydrocephalus, a complication often seen in patients who have experienced aneurysmal Subarachnoid Hemorrhage (aSAH). The outcomes emphasized favorable clinical & economic results associated with the use of this medical solution. This collective effort aims to enhance the overall quality of care and outcomes for individuals affected by this serious medical condition.

By placing an EVD, healthcare providers can consistently monitor the pressure inside the skull and make necessary adjustments to fluid drainage. This ongoing monitoring is essential for evaluating the patient's neurological condition and ensuring timely interventions.

U.S. External Ventricular Drain Market Report Highlights:

  • Based on product, the traumatic brain Injury segment is expected to register the fastest CAGR of 9.50% during the forecast period. TBI can lead to intraventricular bleeding (hemorrhage), requiring the use of EVD devices to remove excess cerebrospinal fluid from the brain. This directly increases the demand for EVD devices, thereby fostering market growth.
  • Based on patient type, the pediatric segment is anticipated to grow at the fastest CAGR of 9.56% during the forecast period owing to the advancements in pediatric neuroimaging technologies, including CT scans & MRIs, which are improving the accuracy and timeliness of diagnosing TBIs in children.
  • Based on end-use, the hospital segment is expected to register the fastest CAGR of 8.32% during the forecast period.Hospitals play a crucial role in diagnosing & managing neurological disorders such as TBI, Intracranial Pressure (ICP), and hydrocephalus. Serving as pivotal centers for patient care, these facilities often possess state-of-the-art medical technology and employ a team of skilled healthcare specialists.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. External Ventricular Drain Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of neurological disorders
      • 3.2.1.2. Increasing healthcare expenditure
      • 3.2.1.3. Developments of novel EVD technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Infections and complications caused due to EVD insertion
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Growing awareness regarding neurological illnesses
      • 3.2.3.2. Increasing demand for minimally invasive procedures
  • 3.3. U.S. External Ventricular Drain Market Analysis Tools
    • 3.3.4. Industry Analysis - Porter's Five Forces
      • 3.3.4.1. Bargaining power of suppliers
      • 3.3.4.2. Bargaining power of buyers
      • 3.3.4.3. Threat of substitutes
      • 3.3.4.4. Threat of new entrants
      • 3.3.4.5. Competitive rivalry
    • 3.3.5. PESTEL Analysis
      • 3.3.5.1. Political & Legal Landscape
      • 3.3.5.2. Economic and Social Landscape
      • 3.3.5.3. Technological landscape

Chapter 4. U.S. External Ventricular Drain Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. External Ventricular Drain Market Movement Analysis
  • 4.3. U.S. External Ventricular Drain Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Traumatic Brain Injury
    • 4.4.1. Traumatic Brain Injury Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Subarachnoid Hemorrhage
    • 4.5.1. Subarachnoid Hemorrhage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Intracerebral Hemorrhage
    • 4.6.1. Intracerebral Hemorrhage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Other Non-traumatic Hydrocephalus Conditions
    • 4.7.1. Other Non-traumatic Hydrocephalus Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. External Ventricular Drain Market: Patient Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. External Ventricular Drain Market Movement Analysis
  • 5.3. U.S. External Ventricular Drain Market Size & Trend Analysis, by Patient Type, 2018 to 2030 (USD Million)
  • 5.4. Adult
    • 5.4.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Pediatric
    • 5.5.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. External Ventricular Drain Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. External Ventricular Drain Market Movement Analysis
  • 6.3. U.S. External Ventricular Drain Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. External Ventricular Drain Market: Country Estimates & Trend Analysis by Application, By Patient Type, By End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size and Trend Analysis, 2018 to 2030
  • 7.3. South
    • 7.3.1. Key country dynamics
    • 7.3.2. Competitive scenario
    • 7.3.3. Regulatory framework
    • 7.3.4. Reimbursement scenario
    • 7.3.5. South Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. West
    • 7.4.1. Key country dynamics
    • 7.4.2. Competitive scenario
    • 7.4.3. Regulatory framework
    • 7.4.4. Reimbursement scenario
    • 7.4.5. West Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Midwest
    • 7.5.1. Key country dynamics
    • 7.5.2. Competitive scenario
    • 7.5.3. Regulatory framework
    • 7.5.4. Reimbursement scenario
    • 7.5.5. Midwest Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Northeast
    • 7.6.1. Key country dynamics
    • 7.6.2. Competitive scenario
    • 7.6.3. Regulatory framework
    • 7.6.4. Reimbursement scenario
    • 7.6.5. Northeast Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Medtronic
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Integra LifeSciences
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. SOPHYSA
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Neuromedex
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
  • 8.3. Heat Map Analysis/ Company Market Position Analysis
  • 8.4. Estimated Company Market Share Analysis, 2023
  • 8.5. List of Other Key Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. External ventricular drain market revenue estimates and forecast, by application, 2018 - 2030 (Million)
  • Table 4 U.S. External ventricular drain market revenue estimates and forecast, by patient type, 2018 - 2030 (Million)
  • Table 5 U.S. External ventricular drain market revenue estimates and forecast, by end use, 2018 - 2030 (Million)
  • Table 6 Key companies undergoing partnerships and collaborations
  • Table 7 Key companies undergoing product mergers and acquisitions
  • Table 8 Key companies undergoing product launch

List of Figures

  • Fig. 1 U.S. external ventricular drain market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market outlook
  • Fig. 9 Segment snapshot, 2023 & 2030 ( application and patient type)
  • Fig. 10 Segment snapshot, 2023 & 2030 (end use)
  • Fig. 11 Market concentration
  • Fig. 12 U.S. external ventricular drain market dynamics
  • Fig. 13 Porter's Five Forces analysis
  • Fig. 14 SWOT analysis, by factor (political, economic, social, technological, legal, and environmental)
  • Fig. 15 U.S. external ventricular drain market: By application Key takeaways
  • Fig. 16 U.S. external ventricular drain market, by application: Market Value, 2023 & 2030
  • Fig. 17 Traumatic brain injury market, 2018 - 2030 (USD Million)
  • Fig. 18 Subarachnoid hemorrhage market, 2018 - 2030 (USD Million)
  • Fig. 19 Intracerebral hemorrhage market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. external ventricular drain market: By patient type Key takeaways
  • Fig. 22 U.S. external ventricular drain market, by patient type market value, 2023 & 2030
  • Fig. 23 Adult market, 2018 - 2030 (USD Million)
  • Fig. 24 Pediatric market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. external ventricular drain market: By end use Key takeaways
  • Fig. 26 U.S. external ventricular drain market, by end use: Market value, 2023 & 2030
  • Fig. 27 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 28 Others market, 2018 - 2030 (USD Million)
  • Fig. 29 Northeast market, 2018 - 2030 (USD Million)
  • Fig. 30 West market, 2018 - 2030 (USD Million)
  • Fig. 31 South market, 2018 - 2030 (USD Million)
  • Fig. 32 Midwest market, 2018 - 2030 (USD Million)
  • Fig. 33 Strategic framework